CTOs on the Move

Urologix

www.urologix.com

 
Urologix, Inc., based in Minneapolis, develops, manufactures, markets and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). Urologix`s Cooled ThermoTherapy™ produces targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort. The Prostiva® RF Therapy System delivers radio frequency energy directly into the prostate, destroying prostate tissue, reducing constriction of the urethra, and thereby relieving BPH symptoms. Both therapies provide safe, effective and lasting relief of the symptoms and obstruction due to BPH. Prostiva is a registered trademark of Medtronic, Inc., used under ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.urologix.com
  • 14405 21st Avenue North Suite 110
    Minneapolis, MN USA 55447
  • Phone: 888.229.0772

Executives

Name Title Contact Details

Similar Companies

Medicatech USA

Medicatech USA is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sammons Preston Inc

Sammons Preston Inc is a Bolingbrook, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cramer Decker Medical

Cramer Decker Medical is a Santa Ana, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Eppendorf North America

Eppendorf AG is a leading supplier of systems and research tools for the biotechnology industry worldwide with a wide range of products including instruments, consumables and reagents. Applications include cell manipulation, complete PCR systems, liquid

NuVasive

NuVasive® is an innovative medical device company focused on developing minimally disruptive surgical products and procedures for the spine. Our mission is to improve the lives of patients who suffer from debilitating back, neck, or leg pain by creating cutting-edge products and procedures that revolutionize spine surgery through focusing on Speed of Innovation®, Absolute Responsiveness®, and Superior Clinical Results. Through innovative technological advancements, NuVasive has successfully progressed major spine surgery to where many patients have experienced extraordinary results—they are often walking the same day of surgery, experiencing less blood loss, spending less time in the hospital, and going back to work within four to six weeks (versus six months). NuVasive is the third largest medical device company in the global spine industry. We feature more than 90 products spanning lumbar, thoracic, and cervical applications, neuromonitoring services, and a biologics portfolio. Our products have been used in hundreds of thousands of spine surgeries. NuVasive had revenues of $811 million in 2015, including sales in over 30 countries, and employs more than 1,600 people globally. Corporate headquarters are in San Diego, California and Amsterdam, the Netherlands serves as international headquarters. The company has additional offices in the U.S. located in the states of Tennessee, Ohio, Maryland, and California. Internationally, NuVasive has additional offices located Puerto Rico, the United Kingdom, Germany, Italy, Australia, Spain, Singapore, and Japan.